Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(6 sites)
United States
Washington University School of Medicine, St Louis, Missouri MD Anderson Cancer Center, Houston, Texas South Texas Accelerated Research Therapeutics, San Antonio, Texas Australia
Royal North Shore Hospital, Saint Leonards, New South Wales Westmead Hospital, Westmead, New South Wales The Alfred Hospital, Melbourne, Victoria